Lucifora J, Durantel D, Belloni L, Barraud L, Villet S, Vincent I E, Margeridon-Thermet S, Hantz O, Kay A, Levrero M, Zoulim F
Université Lyon 1, IFR62 Lyon Est, 69008 Lyon, France.
INSERM, U871, 151 Cours Albert Thomas, 69003 Lyon, France.
J Gen Virol. 2008 Aug;89(Pt 8):1819-1828. doi: 10.1099/vir.0.83659-0.
One of the major problems in gaining further insight into hepatitis B virus (HBV)/host-cell interactions is to improve the existing cellular models for the study of HBV replication. The first objective of this study was to improve the system based on transduction of HepG2 cells with a recombinant baculovirus to study HBV replication. A new HBV recombinant baculovirus, Bac-HBV-1.1, in which the synthesis of pre-genomic RNA is driven by a strong mammalian promoter, was generated. Transduction with this new recombinant baculovirus led to higher levels of HBV replication in HepG2 cells compared with levels obtained with previously described baculovirus vectors. The initiation of a complete HBV DNA replication cycle in Bac-HBV-1.1-transduced HepG2 cells was shown by the presence of HBV replicative intermediates, including covalently closed circular DNA (cccDNA). Only low levels of cccDNA were detected in the nucleus of infected cells. Data showed that cccDNA resulted from the recycling of newly synthesized nucleocapsids and was bound to acetylated histones in a chromatin-like structure. HBV particles released into the supernatant of transduced HepG2 cells were infectious in differentiated HepaRG cells. Several Bac-HBV-1.1 baculoviruses containing HBV strains carrying mutations conferring resistance to lamivudine and/or adefovir were constructed. Phenotypic analysis of these mutants confirmed the results obtained with the transfection procedures. In conclusion, an improved cell-culture system was established for the transduction of replication-competent HBV genomes. This will be useful for future studies of the fitness of HBV mutants.
深入了解乙型肝炎病毒(HBV)/宿主细胞相互作用的主要问题之一是改进现有的用于研究HBV复制的细胞模型。本研究的首要目标是改进基于用重组杆状病毒转导HepG2细胞来研究HBV复制的系统。构建了一种新的HBV重组杆状病毒Bac-HBV-1.1,其中前基因组RNA的合成由一个强哺乳动物启动子驱动。与先前描述的杆状病毒载体相比,用这种新的重组杆状病毒转导导致HepG2细胞中HBV复制水平更高。在Bac-HBV-1.1转导的HepG2细胞中,通过包括共价闭合环状DNA(cccDNA)在内的HBV复制中间体的存在,显示了完整HBV DNA复制周期的起始。在受感染细胞的细胞核中仅检测到低水平的cccDNA。数据表明,cccDNA是由新合成的核衣壳循环产生的,并以染色质样结构与乙酰化组蛋白结合。释放到转导的HepG2细胞上清液中的HBV颗粒在分化的HepaRG细胞中具有感染性。构建了几种含有携带对拉米夫定和/或阿德福韦耐药突变的HBV毒株的Bac-HBV-1.1杆状病毒。这些突变体的表型分析证实了转染程序获得的结果。总之,建立了一种改进的细胞培养系统用于转导具有复制能力的HBV基因组。这将有助于未来对HBV突变体适应性的研究。